Oncotherapeutics
22 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Trial of Selinexor, Ruxolitinib and Methylprednisolone (NCT06225310) | Oncotherapeutics | 2024-08-06 |
| Pilot Study Using Changes in Serum BCMA to Determine Disease Progression in Multiple Myeloma (NCT06209606) | Oncotherapeutics | 2022-12-08 |
| Selinexor Treatment for Multiple Myeloma Patients Who Are Refractory to Lenalidomide-containing Therapy. (NCT04519476) | Oncotherapeutics | 2020-11-01 |
| Ph 2 Maintenance Trial: Ixazomib vs Ixazomib-Lenalidomide for MM Patients (NCT03733691) | Oncotherapeutics | 2019-03-01 |
Track Oncotherapeutics automatically
Every clearance here is in the API, with alerts when new ones post.